mTOR(哺乳动物雷帕霉素靶蛋白):击中增强脑缺血后神经发生的靶心?
缺血性卒中仍是全球致残和致死的主要原因,脑缺血后内源性神经发生对神经修复至关重要。本综述汇总现有证据,提示mTOR信号通路可能增强脑缺血后的神经发生、血管新生和突触可塑性,mTOR可能成为治疗缺血性脑损伤的潜在靶点。
要点
- mTOR激酶被提示可调节神经干细胞自我更新和分化为增殖性子细胞的能力。
- 综述汇总的证据支持mTOR信号通路可能增强脑缺血后的神经发生、血管新生和突触可塑性。
- mTOR可能成为治疗缺血性脑损伤的潜在治疗靶点。
核心结论
- mTOR信号通路可能增强脑缺血后的神经发生、血管新生和突触可塑性,mTOR可能成为治疗缺血性脑损伤的潜在靶点。
研究设计与样本
- 本文为综述,汇总了支持mTOR信号通路在脑缺血后作用的现有证据。
主要发现
- 脑缺血诱导的内源性神经发生在缺血性脑损伤后受损神经细胞的修复和再生中起关键作用。
- mTOR激酶被提示可调节神经干细胞的自我更新及分化为增殖性子细胞的能力,从而改善细胞生长、增殖和存活。
- 综述汇总的证据支持mTOR信号通路可能增强脑缺血后的神经发生、血管新生和突触可塑性。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ischemic stroke remains a leading cause of morbidity and disability around the world. The sequelae of serious neurological damage are irreversible due to body's own limited repair capacity. However, endogenous neurogenesis induced by cerebral ischemia plays a critical role in the repair and regeneration of impaired neural cells after ischemic brain injury. mTOR (mammalian target of rapamycin) kinase has been suggested to regulate neural stem cells ability to self-renew and differentiate into proliferative daughter cells, thus leading to improved cell growth, proliferation, and survival. In this review, we summarized the current evidence to support that mTOR signaling pathways may enhance neurogenesis, angiogenesis, and synaptic plasticity following cerebral ischemia, which could highlight the potential of mTOR to be a viable therapeutic target for the treatment of ischemic brain injury.
引用
- Gao J, Yao M, Chang D, et al. mTOR (Mammalian Target of Rapamycin): Hitting the Bull's Eye for Enhancing Neurogenesis After Cerebral Ischemia? Stroke. 2022. PMID: 36321454. doi:10.1161/STROKEAHA.122.040376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。